$2500 | Single User
$5000 | Site License
$7500 | Enterprise License

Hemoglobinopathies Global Clinical Trials Review, H2, 2017
[Report Updated: 15-09-2017]

Published by Global Data: 15 Sep 2017 | 130975 | In Stock
Related Topics: Clinical Trials

Introduction

Hemoglobinopathies Global Clinical Trials Review, H2, 2017

Summary

GlobalData's clinical trial report, “Hemoglobinopathies Global Clinical Trials Review, H2, 2017" provides an overview of Hemoglobinopathies clinical trials scenario. This report provides top line data relating to the clinical trials on Hemoglobinopathies. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape

- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status

- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company

- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment

- The Report provides enrollment trends for the past five years

- Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment

- Helps in identifying prominent locations for conducting clinical trials which saves time and cost

- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities

- Supports understanding of trials count and enrollment trends by country in global therapeutics market

- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials

- Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table of Contents
for Hemoglobinopathies Global Clinical Trials Review, H2, 2017 [Report Updated: 15-09-2017]

  • Table of Contents

    Table of Contents 2

    List of Tables 3

    List of Figures 3

    Report Guidance 4

    GlobalData Clinical Trials Report Coverage 5

    Clinical Trials by Region 6

    Clinical Trials and Average Enrollment by Country 7

    Top Countries Contributing to Clinical Trials in Asia-Pacific 10

    Top Five Countries Contributing to Clinical Trials in Europe 11

    Top Countries Contributing to Clinical Trials in North America 12

    Top Countries Contributing to Clinical Trials in Middle East and Africa 13

    Clinical Trials by G7 Countries: Proportion of Hemoglobinopathies to Hematological Disorders Clinical Trials 14

    Clinical Trials by Phase in G7 Countries 15

    Clinical Trials in G7 Countries by Trial Status 16

    Clinical Trials by Phase 17

    In Progress Trials by Phase 18

    Clinical Trials by Trial Status 19

    Clinical Trials by End Point Status 20

    Subjects Recruited Over a Period of Time 21

    Clinical Trials by Sponsor Type 22

    Prominent Sponsors 23

    Top Companies Participating in Hemoglobinopathies Therapeutics Clinical Trials 24

    Prominent Drugs 25

    Clinical Trial Profile Snapshots 26

    Appendix 51

    Abbreviations 51

    Definitions 51

    Research Methodology 52

    Secondary Research 52

    About GlobalData 53

    Contact Us 53

    Source 53

List Of Tables
in Hemoglobinopathies Global Clinical Trials Review, H2, 2017 [Report Updated: 15-09-2017]

List of Tables

Hemoglobinopathies Therapeutics, Global, Clinical Trials by Region, 2017* 6

Hemoglobinopathies Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 8

Hemoglobinopathies Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 9

Hemoglobinopathies Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2017* 10

Hemoglobinopathies Therapeutics Clinical Trials, Europe, Top Five Countries, 2017* 11

Hemoglobinopathies Therapeutics Clinical Trials, North America, Top Countries, 2017* 12

Hemoglobinopathies Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2017* 13

Proportion of Hemoglobinopathies to Hematological Disorders Clinical Trials, G7 Countries (%), 2017* 14

Hemoglobinopathies Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 15

Hemoglobinopathies Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 16

Hemoglobinopathies Therapeutics, Global, Clinical Trials by Phase, 2017* 17

Hemoglobinopathies Therapeutics, Global, Clinical Trials In Progress by Phase 2017* 18

Hemoglobinopathies Therapeutics, Global, Clinical Trials by Trial Status, 2017* 19

Hemoglobinopathies Therapeutics Clinical Trials, Global, by End Point Status, 2017* 20

Hemoglobinopathies Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 21

Hemoglobinopathies Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2017* 22

Hemoglobinopathies Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 23

Hemoglobinopathies Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 24

Hemoglobinopathies Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 25

List Of Figures, Charts and Diagrams
in Hemoglobinopathies Global Clinical Trials Review, H2, 2017 [Report Updated: 15-09-2017]

List of Figures

Hemoglobinopathies Therapeutics, Global, Clinical Trials by Region (%), 2017* 6

Hemoglobinopathies Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 7

Hemoglobinopathies Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 9

Hemoglobinopathies Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2017* 10

Hemoglobinopathies Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2017* 11

Hemoglobinopathies Therapeutics Clinical Trials, North America, Top Countries (%), 2017* 12

Proportion of Hemoglobinopathies to Hematological Disorders Clinical Trials, G7 Countries (%), 2017* 14

Hemoglobinopathies Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 15

Hemoglobinopathies Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 16

Hemoglobinopathies Therapeutics, Global, Clinical Trials by Phase (%), 2017* 17

Hemoglobinopathies Therapeutics, Global, Clinical Trials In Progress by Phase, 2017* 18

Hemoglobinopathies Therapeutics, Global, Clinical Trials by Trial Status, 2017* 19

Hemoglobinopathies Therapeutics Clinical Trials, Global, by End Point Status, 2017* 20

Hemoglobinopathies Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 21

Hemoglobinopathies Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2017* 22

Hemoglobinopathies Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 23

Hemoglobinopathies Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 24

Hemoglobinopathies Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 25

GlobalData Methodology 52

Additional Details

Publisher

Global Data

Publisher Information

Reference

130975 | GDHC4555CTIDB

Number of Pages

53

Report Format

PDF

Global Data Reports

Related Reports

TitleDate PublishedPrice fromMore Details
Hemoglobinopathies- Market Insights, Epidemiology and Market Forecast 2028
Report Summary"Hemoglobinopathies- Market Insights, Epidemiology and Market Forecast 2028" report pr...
26 Jul 2019 by MIReports USD $5,980 More Info
2019 Hemoglobinopathies Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025
The global clinical trial report- “2019 Hemoglobinopathies Clinical Trials Study” provides complete ...
24 Apr 2019 by VPA Research USD $1,799 More Info

This report is published by Global Data

Download Free Report Summary PDF

Hemoglobinopathies Global Clinical Trials Review, H2, 2017 [Report Updated: 15-09-2017] | Download PDF Summary

Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.

Ordering Information

Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.

Accepted Card Types

Payment

Buy now using our secure payment system.

We Stock...